Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Long Term Debt Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual long term debt in 2021 was - USD , down -100.0% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly long term debt in 2022 Q2 was - USD , down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported annual long term debt of 87.17 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported quarterly long term debt of - USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported quarterly long term debt of - USD for 2021 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Long Term Debt of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Long Term Debt Long Term Debt Growth
2021 - USD -100.0%
2020 87.17 Million USD 0.0%

Peer Long Term Debt Comparison of Clarus Therapeutics Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
AstraZeneca PLC 22.33 Billion USD 100.0%
Bristol-Myers Squibb Company PFD CONV 2 38.18 Billion USD 100.0%
CSPC Pharmaceutical Group Limited 107.05 Million USD 100.0%
Novartis AG 20.03 Billion USD 100.0%
PT Kalbe Farma Tbk. 19.39 Million USD 100.0%